LG-2527
LG-2527 is a nonsteroidal progestin which was under development by Ligand Pharmaceuticals and Wyeth for the treatment of menopausal symptoms and breast cancer, but was never marketed.
≈ 1 min read
LG-2527. encyclopegia.org, snapshot enwiki-001239044753. /a/lg-2527
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
LG-2527 is a nonsteroidal progestin which was under development by Ligand Pharmaceuticals and Wyeth for the treatment of menopausal symptoms and breast cancer, but was never marketed. It reached the preclinical stage of development prior to the discontinuation of its development in early 2001.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1239044753 under CC BY-SA 4.0; modifications have been made.